Exane Derivatives’s Goldman Sachs GS Stock Holding History

Exane Derivatives’s Portfolio GS Stock Details GS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2.08K	Sell	7 -343	-98%	-$107K	﹤0.01%	436
2022 Q1	$116K	Sell	350 -2,149	-86%	-$759K	0.03%	449
2021 Q4	$956K	Buy	2,499 +873	+54%	+$346K	0.23%	97
2021 Q3	$615K	Sell	1,626 -515	-24%	-$201K	0.15%	148
2021 Q2	$805K	Buy	2,141 +838	+64%	+$300K	0.18%	105
2021 Q1	$426K	Buy	1,303 +1,299	+32,475%	+$404K	0.12%	168
2020 Q4	$1.05K	Hold	4	–	–	﹤0.01%	673
2020 Q3	$804	Sell	4 -65	-94%	-$13.2K	﹤0.01%	638
2020 Q2	$13.6K	Buy	69 +42	+156%	+$7.88K	﹤0.01%	405
2020 Q1	$4.17K	Hold	27	–	–	﹤0.01%	460
2019 Q4	$6.62K	Sell	27 -208	-89%	-$45.1K	﹤0.01%	423
2019 Q3	$48.7K	Hold	235	–	–	0.01%	370
2019 Q2	$48.1K	Sell	235 -259	-52%	-$51.3K	0.01%	393
2019 Q1	$94.8K	Sell	494 -554	-53%	-$107K	0.02%	298
2018 Q4	$175K	Buy	1,048 +700	+201%	+$141K	0.03%	265
2018 Q3	$78.7K	Sell	348 -130	-27%	-$30.2K	0.01%	342
2018 Q2	$107K	Buy	478 +132	+38%	+$31.5K	0.02%	327
2018 Q1	$85.8K	Buy	346 +187	+118%	+$48.7K	0.02%	318
2017 Q4	$40.5K	Sell	159 -1,026	-87%	-$252K	0.01%	357
2017 Q3	$281K	Sell	1,185 -104	-8%	-$23.5K	0.05%	180
2017 Q2	$286K	Sell	1,289 -824	-39%	-$183K	0.06%	178
2017 Q1	$485K	Buy	2,113 +181	+9%	+$43.7K	0.11%	133
2016 Q4	$463K	Buy	1,932 +881	+84%	+$179K	0.09%	159
2016 Q3	$169K	Sell	1,051 -30	-3%	-$4.88K	0.03%	212
2016 Q2	$161K	Buy	1,081 +705	+188%	+$110K	0.03%	213
2016 Q1	$59K	Hold	376	–	–	0.01%	284
2015 Q4	$67.8K	Buy	+376	New	+$69.9K	0.01%	243

Other funds holding GS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Exane Derivatives's GS Position: Q2 2022 in Review

Exane Derivatives reduced its Goldman Sachs (GS) stake by 98% in Q2 2022, selling an estimated $107K and leaving 7 shares worth $2.08K. The position accounts for ﹤0.01% of the portfolio, ranked #436.

Exane Derivatives first reported a position in GS in Q4 2015 and has held it in 27 quarters since. The position peaked at $956K in Q4 2021. 1,771 funds tracked by Wall St. Rank hold GS as of Q2 2022.

Exane Derivatives held 7 shares of Goldman Sachs worth $2.08K as of Q2 2022.
Exane Derivatives sold 343 Goldman Sachs shares in Q2 2022, an estimated $107K.
Goldman Sachs made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #436 holding.
Exane Derivatives first reported a position in Goldman Sachs in Q4 2015 and has held it in 27 quarters since.
Exane Derivatives's Goldman Sachs position peaked at $956K in Q4 2021.
1,771 funds tracked by Wall St. Rank held Goldman Sachs as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.